androgen deprivation therapy trang 2 tải miễn phí từ TAILIEUCHUNG

"androgen deprivation therapy" trang 2 - tải miễn phí từ Tailieuchung

Intermediate PSA half-life after neoadjuvant hormone therapy predicts reduced risk of castration-resistant prostate cancer development after radical prostatectomy

Intermediate PSA half-life after neoadjuvant hormone therapy predicts reduced risk of castration-resistant prostate cancer development after radical prostatectomy

8 42 1

Platelet to lymphocyte ratio as an independent prognostic indicator for prostate cancer patients receiving androgen deprivation therapy

Platelet to lymphocyte ratio as an independent prognostic indicator for prostate cancer patients receiving androgen deprivation therapy

8 48 1

Toremifene, a selective estrogen receptor modulator, significantly improved biochemical recurrence in bone metastatic prostate cancer: A randomized controlled phase II a trial

Toremifene, a selective estrogen receptor modulator, significantly improved biochemical recurrence in bone metastatic prostate cancer: A randomized controlled phase II a trial

8 47 1

Surveillance or metastasis-directed Therapy for OligoMetastatic Prostate cancer recurrence (STOMP): Study protocol for a randomized phase II trial

Surveillance or metastasis-directed Therapy for OligoMetastatic Prostate cancer recurrence (STOMP): Study protocol for a randomized phase II trial

6 24 1

Báo cáo khoa học:

Báo cáo khoa học: "Early prediction of response to radiotherapy and androgen-deprivation therapy in prostate cancer by repeated functional MRI: a preclinical study"

9 80 0

Báo cáo khoa học:

Báo cáo khoa học: "Expanded risk groups help determine which prostate radiotherapy sub-group may benefit from adjuvant androgen deprivation therapy"

8 64 0

Protocol for a phase III RCT and economic analysis of two exercise delivery methods in men with PC on ADT

Protocol for a phase III RCT and economic analysis of two exercise delivery methods in men with PC on ADT

18 70 0

Treatment in the STAMPEDE era for castrate resistant prostate cancer in the UK: ongoing challenges and underappreciated clinical problems

Treatment in the STAMPEDE era for castrate resistant prostate cancer in the UK: ongoing challenges and underappreciated clinical problems

10 40 1

Impact of resistance training on body composition and metabolic syndrome variables during androgen deprivation therapy for prostate cancer: A pilot randomized controlled trial

Impact of resistance training on body composition and metabolic syndrome variables during androgen deprivation therapy for prostate cancer: A pilot randomized controlled trial

15 48 1

Identification of a candidate prognostic gene signature by transcriptome analysis of matched pre- and post-treatment prostatic biopsies from patients with advanced prostate cancer

Identification of a candidate prognostic gene signature by transcriptome analysis of matched pre- and post-treatment prostatic biopsies from patients with advanced prostate cancer

10 19 1

Multi-transcript profiling in archival diagnostic prostate cancer needle biopsies to evaluate biomarkers in non-surgically treated men

Multi-transcript profiling in archival diagnostic prostate cancer needle biopsies to evaluate biomarkers in non-surgically treated men

10 33 1

$Effects of once-yearly zoledronic acid on bone density and incident vertebral fractures in nonmetastatic castrationsensitive prostate cancer patients with osteoporosis$

Effects of once-yearly zoledronic acid on bone density and incident vertebral fractures in nonmetastatic castrationsensitive prostate cancer patients with osteoporosis

7 26 1

CKAP2L, a crucial target of miR-326, promotes prostate cancer progression

CKAP2L, a crucial target of miR-326, promotes prostate cancer progression

11 18 1

The effects and mechanism of YK-4-279 in combination with docetaxel on prostate cancer

The effects and mechanism of YK-4-279 in combination with docetaxel on prostate cancer

11 55 0

Effectiveness of community-based football compared to usual care in men with prostate cancer: Protocol for a randomised, controlled, parallel group, multicenter superiority trial (The FC Prostate Community Trial)

Effectiveness of community-based football compared to usual care in men with prostate cancer: Protocol for a randomised, controlled, parallel group, multicenter superiority trial (The FC Prostate Community Trial)

10 52 1

Androgen Deprivation therapy for Oligo-recurrent Prostate cancer in addition to radioTherapy (ADOPT): Study protocol for a randomised phase III trial

Androgen Deprivation therapy for Oligo-recurrent Prostate cancer in addition to radioTherapy (ADOPT): Study protocol for a randomised phase III trial

8 12 1

ALDH1A3 serves as a predictor for castration resistance in prostate cancer patients

ALDH1A3 serves as a predictor for castration resistance in prostate cancer patients

8 66 0

Đã phát hiện trình chặn quảng cáo AdBlock

Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.